These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 3470919

  • 21. In vitro dissolution profiles of enteric-coated microsphere/microtablet pancreatin preparations at different pH values.
    Gan KH, Geus WP, Bakker W, Lamers CB, Heijerman HG.
    Aliment Pharmacol Ther; 1996 Oct; 10(5):771-5. PubMed ID: 8899086
    [Abstract] [Full Text] [Related]

  • 22. [Therapy of pancreatogenic steatorrhea. Comparison of 2 acid-protected enzyme preparations].
    Lankisch PG, Lembcke B, Kirchhoff S, Hilgers R, Creutzfeldt W.
    Dtsch Med Wochenschr; 1988 Jan 08; 113(1):15-7. PubMed ID: 3335192
    [Abstract] [Full Text] [Related]

  • 23. Development of pancreatic enzyme microsphere technology and US findings with Pancrease in the treatment of chronic pancreatitis.
    DeYoung JL.
    Int J Pancreatol; 1989 Jan 08; 5 Suppl():31-6. PubMed ID: 2702248
    [Abstract] [Full Text] [Related]

  • 24. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century.
    Trang T, Chan J, Graham DY.
    World J Gastroenterol; 2014 Sep 07; 20(33):11467-85. PubMed ID: 25206255
    [Abstract] [Full Text] [Related]

  • 25. Alipase versus nonenteric-coated enzymes in pancreatic insufficiency. A french multicenter crossover comparative study.
    Gouerou H, Dain MP, Parrondo I, Poisson D, Bernades P.
    Int J Pancreatol; 1989 Sep 07; 5 Suppl():45-50. PubMed ID: 2702250
    [Abstract] [Full Text] [Related]

  • 26. In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability.
    Aloulou A, Puccinelli D, Sarles J, Laugier R, Leblond Y, Carrière F.
    Aliment Pharmacol Ther; 2008 Feb 01; 27(3):283-92. PubMed ID: 17973644
    [Abstract] [Full Text] [Related]

  • 27. Medical treatment of pancreatic insufficiency.
    DiMagno EP.
    Mayo Clin Proc; 1979 Jul 01; 54(7):435-42. PubMed ID: 36518
    [Abstract] [Full Text] [Related]

  • 28. Treatment of steatorrhoea in cystic fibrosis: a comparison of enteric-coated microspheres of pancreatin versus non-enteric-coated pancreatin and adjuvant cimetidine.
    Stead RJ, Skypala I, Hodson ME.
    Aliment Pharmacol Ther; 1988 Dec 01; 2(6):471-82. PubMed ID: 2979269
    [Abstract] [Full Text] [Related]

  • 29. [Does enzyme substitution therapy reduce pain in chronic pancreatitis?].
    Hansen ML, Rumessen JJ.
    Ugeskr Laeger; 2005 Apr 25; 167(17):1841-4. PubMed ID: 15929329
    [No Abstract] [Full Text] [Related]

  • 30. Monitoring enzyme replacement treatment in exocrine pancreatic insufficiency using the cholesteryl octanoate breath test.
    Mundlos S, Kühnelt P, Adler G.
    Gut; 1990 Nov 25; 31(11):1324-8. PubMed ID: 2253920
    [Abstract] [Full Text] [Related]

  • 31. Study of the gastrointestinal bioavailability of a pancreatic extract product (Zenpep) in chronic pancreatitis patients with exocrine pancreatic insufficiency.
    Lieb JG, Patel D, Karnik N, Toskes PP.
    Pancreatology; 2020 Sep 25; 20(6):1092-1102. PubMed ID: 32800653
    [Abstract] [Full Text] [Related]

  • 32. Enzyme treatment of exocrine pancreatic insufficiency in chronic pancreatitis.
    Lankisch PG.
    Digestion; 1993 Sep 25; 54 Suppl 2():21-9. PubMed ID: 8224569
    [Abstract] [Full Text] [Related]

  • 33. Comparative in vitro and in vivo studies of enteric-coated pancrelipase preparations for pancreatic insufficiency.
    Thomson M, Clague A, Cleghorn GJ, Shepherd RW.
    J Pediatr Gastroenterol Nutr; 1993 Nov 25; 17(4):407-13. PubMed ID: 8145097
    [Abstract] [Full Text] [Related]

  • 34. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy].
    Löser C, Fölsch UR.
    Leber Magen Darm; 1991 Mar 25; 21(2):56, 59-62, 65. PubMed ID: 1710011
    [Abstract] [Full Text] [Related]

  • 35. [Requirements for successful pancreatic enzyme replacement therapy (comparative study of Kreon and Panpur)].
    Pap A, Korom M, Marosi E, Varró V.
    Orv Hetil; 1990 Feb 04; 131(5):241-4. PubMed ID: 2304764
    [Abstract] [Full Text] [Related]

  • 36. Pancreatic enzyme therapy for pancreatic exocrine insufficiency.
    Domínguez-Muñoz JE.
    Curr Gastroenterol Rep; 2007 Apr 04; 9(2):116-22. PubMed ID: 17418056
    [Abstract] [Full Text] [Related]

  • 37. New modalities in the treatment of exocrine pancreatic insufficiency in cystic fibrosis.
    Heijerman HG.
    Neth J Med; 1992 Oct 04; 41(3-4):105-9. PubMed ID: 1470278
    [Abstract] [Full Text] [Related]

  • 38. Proteolytic inactivation of lipase as a possible cause of the uneven results obtained with enzyme substitution in pancreatic insufficiency.
    Pap A, Varró V.
    Hepatogastroenterology; 1984 Feb 04; 31(1):47-50. PubMed ID: 6199274
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of lower than standard doses of pancreatic enzyme supplementation therapy during acid inhibition in patients with pancreatic exocrine insufficiency.
    Vecht J, Symersky T, Lamers CB, Masclee AA.
    J Clin Gastroenterol; 2006 Sep 04; 40(8):721-5. PubMed ID: 16940886
    [Abstract] [Full Text] [Related]

  • 40. Two enteric coated microspheres in cystic fibrosis.
    Williams J, MacDonald A, Weller PH, Fields J, Pandov H.
    Arch Dis Child; 1990 Jun 04; 65(6):594-7. PubMed ID: 2198848
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.